Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2017

Aug 3, 2017

32853_dirs_2017-08-02_09953508-2949-4183-8494-27cb37bc4a69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2017-07-31

Reporting Person: COLELLA SAMUEL D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-31 Common Stock M 5000 Acquired 45197 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-07-31 Restricted Stock Units $ M 5000 Disposed 2017-07-31 Common Stock (5000.0) Direct
2017-08-01 Restricted Stock Units $ A 5000 Acquired Common Stock (5000.0) Direct
2017-08-01 Stock Option (Right to Buy) $3.43 A 5000 Acquired 2027-08-01 Common Stock (5000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5561 Indirect
Common Stock 17500 Indirect
Common Stock 3326 Indirect

Footnotes

F1: The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of Versant Venture Capital I, L.P., Versant Side Fund I, L.P., Versant Affiliates Fund I-A, L.P. and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"), on November 4, 2013. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.

F3: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director through the vesting date.

F4: 1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 1, 2018.